2025-08-18T10:22:38-05:00 2024-12-31 521186096 RUBINO AND COMPANY CHARTERED 6903 ROCKLEDGE DRIVE SUITE 300 BETHESDA MD 208171818 990 2024-01-01 521694732 SOCIETY FOR WOMEN'S HEALTH RESEARCH SOCI 2022238224 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 KATHRYN SCHUBERT PRESIDENT & CEO 2022238224 2025-08-18 1 0 KAY VOLLANS CPA P01404047 3015643636 2024 2025-03-06 01:10:19Z KATHRYN SCHUBERT 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 3865730 0 X WWW.SWHR.ORG X 1990 DC TO IMPROVE THE HEALTH OF WOMEN THROUGH SCIENCE, POLICY, AND EDUCATION. 11 11 15 13 0 0 2470544 2540492 0 0 46518 128360 -57455 -142228 2459607 2526624 3600 0 0 0 1327334 1553495 0 0 129718 545390 816678 1876324 2370173 583283 156451 3579022 3693359 566056 481004 3012966 3212355 ADVANCE WOMEN'S HEALTH THROUGH SCIENCE, POLICY, AND EDUCATION WHILE PROMOTING RESEARCH ON SEX DIFFERENCES TO OPTIMIZE WOMEN'S HEALTH. 0 0 1123918 SCIENTIFIC, SWHR NETWORKS, AND BOSD JOURNAL - SWHR MAINTAINS A DIALOGUE WITH THE PUBLIC AND PRIVATE SECTOR RESEARCH COMMUNITIES TO EDUCATE THEM ABOUT THE NEED FOR RESEARCH IN WOMEN'S HEALTH AND THE STUDY OF SEX DIFFERENCES. SWHR CO-OWNS THE BIOLOGY OF SEX DIFFERENCE JOURNAL (TO ENHANCE THE KNOWLEDGE OF SEX AND GENDER DIFFERENCES). SWHR CONVENES INTERDISCIPLINARY WORKING GROUP MEMBERS THAT INCLUDE RESEARCHERS, CLINICIANS, PATIENTS, AND OTHER EXPERTS TO ADDRESS GAPS IN KNOWLEDGE AND UNMET NEEDS IN WOMEN'S HEALTH ACROSS THE LIFESPAN. 727999 POLICY AND ADVOCACY - SWHR SEEKS TO INCREASE FEDERAL FUNDING FOR BIOMEDICAL RESEARCH FOR CONDITIONS THAT AFFECT WOMEN AND FOR SEX DIFFERENCES RESEARCH. SWHR SEEKS TO ENSURE THAT WOMEN ARE INCLUDED APPROPRIATELY IN CLINICAL TRIALS, THAT TRIAL RESULTS (RESEARCH FINDINGS) ARE ANALYZED FOR SEX AND GENDER DIFFERENCES, AND THAT APPROPRIATE FUNDING IS PROVIDED FOR THE OFFICES OF WOMEN'S HEALTH AT NIH, HHS, AND FDA. FURTHERMORE, SWHR ADVOCATES FOR IMPROVED REGULATORY POLICY, COVERAGE AND PAYMENT POLICY, AND PRIVATE HEALTH PLAN POLICY TO BENEFIT THE HEALTH OF WOMEN. 166237 COMMUNICATIONS - SWHR EDUCATES WOMEN IN THE PUBLIC ABOUT THE VALUE OF BIOMEDICAL RESEARCH AND THE LATEST FINDINGS ABOUT DISEASE PREVENTION, DIAGNOSIS, AND TREATMENT OPTIONS. 2018154 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 13 0 1 15 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 DC X YONAS FSAHAYE 2022238224 1025 CONNECTICUT AVE NW 1104 WASHINGTON DC 20036 KATHRYN SCHUBERT MPP CAE PRESIDENT & CEO 37.50 X 332813 0 57746 YONAS FSAHAYE MBA CFO 37.50 X 181499 0 17649 IRENE O ANINYE CHIEF SCIENCE OFFICER 37.50 X 150023 0 22038 LINDSEY N MILTENBERGER CHIEF ADVOCACY OFFICER 37.50 X 124028 0 16254 JULIE MILLER DEVELOPMENT DIRECTOR 37.50 X 107367 0 39820 GRETTA STONE BOARD CHAIR 3.00 X X 0 0 0 SHONTELLE DODSON PHARMD IMMEDIATE PAST CHAIR 3.00 X X 0 0 0 JENELLE KRISHNAMOORTHY PHD SECRETARY-TREASURER 3.00 X X 0 0 0 PATTI COMPTON MS EXECUTIVE COMMITTEE DIRECTOR 3.00 X 0 0 0 ERIKA MILLER JD EXECUTIVE COMMITTEE DIRECTOR 3.00 X 0 0 0 JIM CAREY DIRECTOR 3.00 X 0 0 0 ANNE B CROPP PHARMD BCAP DIRECTOR 3.00 X 0 0 0 LINDA G GRIFFITH PHD DIRECTOR 3.00 X 0 0 0 JUDETTE LOUIS MD MPH DIRECTOR 3.00 X 0 0 0 MARIANNE SLIGHT DIRECTOR 3.00 X 0 0 0 MICHAEL YBARRA MD DIRECTOR 3.00 X 0 0 0 895730 0 153507 5 0 1 0 0 380000 453500 1706992 2540492 131991 131991 1192484 1196115 -3631 -3631 -3631 0 453500 142991 -142991 -142991 763 763 763 2526624 0 0 -13868 X 478657 382925 95732 790505 657756 46003 86746 82339 60130 7707 14502 96213 86844 9369 105781 94103 4925 6753 425 425 18050 18050 9315 9315 328658 328658 115935 114905 35 995 176366 145082 19558 11726 27398 25862 860 676 100815 97823 1627 1365 7635 6264 837 534 7667 7667 SUBSCRIPTIONS 17993 17802 191 LICENSES & FEES 6421 6421 2370173 2018154 222301 129718 583653 69025 356776 225000 2437 60 33836 30245 69913 27239 8662 42674 2565043 2708570 385391 261009 3579022 3693359 60804 37626 105000 175000 400252 268378 566056 481004 X 1615346 2299982 1397620 912373 3012966 3212355 3579022 3693359 156451 42938 0 X X 0 1 X 1 0 X 1641615 2158435 1980941 2470544 2540492 10792027 1641615 2158435 1980941 2470544 2540492 10792027 3604014 7188013 30744 37205 53831 46155 86122 254057 11046084 0.65070 0.66270 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 18803 6681 12122 51110 20558 30552 42674 SECURITY DEPOSITS 21214 OPERATING LEASE RIGHT OF USE ASSET 239795 261009 OPERATING LEASE LIABILITY 268378 268378 X 2560247 42938 42938 2517309 9315 9315 2526624 2360858 0 2360858 9315 9315 2370173 PART X, LINE 2: SWHR IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES (EXCEPT TAXES ON UNRELATED BUSINESS INCOME) UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED BY THE INTERNAL REVENUE SERVICE AS OTHER THAN A PRIVATE FOUNDATION. NO PROVISION FOR INCOME TAXES IS REQUIRED FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 SINCE SWHR HAD NO TAXABLE INCOME FROM UNRELATED BUSINESS ACTIVITIES. THE INCOME TAX POSITIONS TAKEN BY SWHR FOR ANY YEARS OPEN UNDER THE VARIOUS STATUTES OF LIMITATIONS ARE THAT SWHR CONTINUES TO BE EXEMPT FROM INCOME TAXES AND THAT THEY HAVE PROPERLY REPORTED UNRELATED BUSINESS INCOME THAT IS SUBJECT TO INCOME TAXES. SWHR BELIEVES THAT THERE ARE NO TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD SIGNIFICANTLY INCREASE UNRECOGNIZED TAX LIABILITIES WITHIN 12 MONTHS OF THE REPORTING DATE. NONE OF SWHR'S FEDERAL OR STATE INCOME TAX RETURNS ARE CURRENTLY UNDER EXAMINATION. GALA EVENT 453500 453500 142991 453500 453500 142991 142991 -142991 X X X 0 0 0 0 0 0 0 1 0 KATHRYN SCHUBERT MPP CAE PRESIDENT & CEO 278813 0 54000 0 0 0 30456 0 27290 0 390559 0 0 0 YONAS FSAHAYE MBA CFO 164999 0 16500 0 0 0 16335 0 1314 0 199148 0 0 0 IRENE O ANINYE CHIEF SCIENCE OFFICER 149023 0 1000 0 0 0 13590 0 8448 0 172061 0 0 0 PART I, LINE 7 THE CEO'S BONUS AT SWHR IS DETERMINED BY THE EXECUTIVE COMMITTEE BASED ON HER PERFORMANCE. THE RESPONSIBILITY FOR SWHR STAFF SALARIES AND BONUSES LIES WITH THE CEO. BEFORE IMPLEMENTING ANY SALARY INCREASES OR BONUSES, SWHR COLLECTS SALARY AND BENEFITS SURVEY DATA FROM THE ASAE SURVEY ANNUALLY. THE CEO'S EVALUATION FOR BONUS CONSIDERATIONS INCLUDES ASSESSING STAFF PERFORMANCE, REVENUE, YEARS OF SERVICE, AND OTHER RELEVANT CRITERIA AS PART OF THE EVALUATION PROCESS. FORM 990, PART VI, SECTION B, LINE 11B THE DRAFT IRS FORM 990 IS SHARED VIA EMAIL WITH THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MEETS VIRTUALLY TO REVIEW THE FORM BEFORE THE CHIEF EXECUTIVE OFFICER SIGNS IT. THE EXECUTIVE COMMITTEE WILL INCLUDE A SUMMARY OF THIS REVIEW IN ITS NEXT REPORT TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C SWHR'S CONFLICT OF INTEREST STATEMENT IS SENT ANNUALLY TO EACH BOARD MEMBER (VIA EMAIL AND MAIL) WITH A REQUEST THAT EACH MEMBER SIGN AND RETURN IT. STAFF FOLLOW UP TO ENSURE THAT ALL BOARD MEMBERS SIGN THE DOCUMENT BEFORE THE FIRST MEETING OF THE BOARD EACH YEAR. AT THAT MEETING, ANY MEMBERS WHO HAVE NOT SIGNED ALREADY ARE GIVEN AN OPPORTUNITY TO SIGN IT. ANY BOARD MEMBER WHO REFUSES TO SIGN THE STATEMENT IS ASKED TO RESIGN FROM THE BOARD. FORM 990, PART VI, SECTION B, LINE 15A THE CEO'S PERFORMANCE IS REVIEWED ANNUALLY BY SWHR'S EXECUTIVE COMMITTEE PRIOR TO THE ANNIVERSARY DATE OF THE CEO'S CONTRACT BASED UPON PERFORMANCE CRITERIA AND GOALS PROVIDED IN WRITING TO THE CEO AT THE BEGINNING OF THE PERIOD UNDER REVIEW. THE EXECUTIVE COMMITTEE USES DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS IN MAKING DECISIONS ABOUT ANY RAISES IN COMPENSATION FOR THE CEO. ANY MEMBERS OF THE EXECUTIVE COMMITTEE WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENTS ARE NOT INVOLVED IN THE REVIEW AND APPROVAL. A SUMMARY OF THE ACTIONS TAKEN BY THE EXECUTIVE COMMITTEE IS PRESENTED BY THE COMMITTEE CHAIR TO AN EXECUTIVE SESSION OF THE BOARD. THE SUMMARY INCLUDES: 1. THE COMMITTEE MEMBERS PRESENT DURING THE DISCUSSION AND THOSE WHO VOTED ON IT, 2. THE COMPARABILITY DATA USED AND HOW IT WAS OBTAINED, 3. THE TERMS AND DATE OF THE APPROVED COMPENSATION, AND 4. THE RATIONALE FOR DETERMINING WHY EXECUTIVE COMPENSATION MIGHT EXCEED THAT OF A COMPARABLE ORGANIZATION OR MARKET. ALL OTHER STAFF ARE REVIEWED BY THE ORGANIZATION'S CEO AND/OR DIRECT SUPERVISORS, WITH ULTIMATE APPROVAL OF REVIEWS BY THE CEO. STAFF REVIEWS CONSIST OF VERBAL FEEDBACK, MEETINGS WITH THEIR SUPERVISORS, AND WRITTEN SUPERVISOR COMMENTS. COMPENSATION DECISIONS ARE BASED ON THE REVIEWS AND COMPARABILITY DATA FROM SIMILAR ORGANIZATIONS. FORM 990, PART VI, SECTION C, LINE 19 SWHR'S GOVERNING DOCUMENTS AND BOARD POLICIES, INCLUDING THE CONFLICT OF INTEREST POLICY, ARE POSTED ON SWHR'S WEBSITE. FINANCIAL STATEMENTS AND 990 ARE AVAILABLE UPON REQUEST AND CAN BE SENT VIA HARD COPY MAIL OR E-MAIL. THE FINANCIALS AND 990 ARE ALSO AVAILABLE ON VARIOUS CHARITY WEBSITES FOR PUBLIC REVIEW. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 328,658. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 328,658. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR